logo
Отправить сообщение
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
О нас
Ваш профессиональный и надежный партнер.
Компания Hefei Home Sunshine Pharmaceutical Technology Co., Ltd., основанная в 2013 году, расположена в городе Хэфэй, Китай. Компания сертифицирована по стандарту ISO 9001:2015 и в основном занимается поставками API (активных фармацевтических ингредиентов), промежуточных продуктов и тонких химикатов. Мы рассматриваем качество продукции и доверие как основу жизни предприятия.Команда менеджеров имеет более 15 лет опыта работы в отрасли и уделяет пристальное внимание динамике рынка. Обладая острым ...
Узнайте больше

0

Год основания

0

Миллион+
Работники

0

Миллион+
обслуживание клиентов

0

Миллион+
Годовой объем продаж
Китай Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd ВЫСОКОЕ КАЧЕСТВО
Знак доверия, проверка кредитной истории, RoSH и оценка возможностей поставщика. Компания имеет строгую систему контроля качества и профессиональную испытательную лабораторию.
Китай Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd Развитие
Внутренняя профессиональная команда дизайнеров и мастерская передовых машин. Мы можем сотрудничать, чтобы разработать продукты, которые вам нужны.
Китай Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd Производство
Продвинутые автоматические машины, строгая система управления процессом. Мы можем изготовить все электрические терминалы за пределами вашего спроса.
Китай Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd 100% СЕРВИС
Насыщенная и индивидуальная небольшая упаковка, FOB, CIF, DDU и DDP. Позвольте нам помочь вам найти лучшее решение для всех ваших проблем.

качество Ингредиент API активный фармацевтический & Фармацевтические промежуточные продукты производитель

Найдите продукты, которые лучше отвечают вашим требованиям.

Рекомендуемые продукты

Найдите продукты, которые лучше отвечают вашим требованиям.
Больше продуктов
Случаи и новости
Последние горячие точки.
We supply resin products used in the production of peptide active pharmaceutical ingredients
Resin, as a key carrier material in the solid-phase synthesis process of peptide raw materials, directly determines the efficiency, purity, and quality stability of peptide chain synthesis and the final product. With the rapid development of the biomedical industry, peptide drugs have become the research and development hotspot and core growth point of the market in the treatment of major diseases such as diabetes, cancer and cardiovascular diseases due to their unique advantages of high specificity, high activity and low toxicity. API KSM CAS No Mazdutide Fmoc-Rink Amide AM resin (100-200 mesh, 1.2-1.6 mmol/g) 183599-10-2 Mazdutide 2-Chlorotrityl Chloride Resin(100-200mesh, 1.2-1.6 mmol/g) 42074-68-0 Mazdutide Wang Resin(100-200 mesh, 0.5-0.8 mmol/g) 1365700-43-1 Cagrlinitide Fmoc-Rink Amide MBHA Resin (100-200mesh 0.3 to 0.8 mmol/g) 431041-83-7 Cagrlinitide Fmoc-Rink Amide AM Resin (100-200mesh 0.3 to 0.8 mmol/g) 183599-10-2 Cagrlinitide 2-Chlorotrityl Chloride Resin(100-200mesh, 1.2-1.6 mmol/g) 934816-82-7 Currently, the demand for peptide drugs in the market continues to rise, and the industry has broad development prospects. We adhere to the business philosophy of "integrity-based, quality first, customer first", and sincerely invite enterprises and research institutions engaged in the research and production of peptide active pharmaceutical ingredients from around the world to consult and purchase. We will assist you in smoothly advancing your projects in the peptide drug field with cost-effective products and customized services, and work together with you to explore new market opportunities and share the dividends of industry development! Double guarantee of quality and service, choose our four core advantages: 1. Strict quality control system, stable and reliable qualityEstablish a full chain quality control system from raw material procurement, production synthesis to finished product delivery, equipped with precision testing equipment such as high-performance liquid chromatography (HPLC), elemental analyzer, particle size analyzer, etc., to strictly test key indicators such as loading capacity, cross-linking degree, particle size distribution, impurity content, stability, etc. of each batch of products. The product meets the pharmacopoeia standards and GMP requirements for peptide raw material production, with minimal quality fluctuations between batches, providing a solid guarantee for the stability of the customer's production process. 2. Mature production capacity to ensure large-scale supplyWe have modern production bases and standardized production lines, equipped with multiple sets of professional production equipment, which can achieve a step-by-step supply from laboratory small-scale (gram level), pilot scale (kilogram level) to industrial mass production (ton level). Whether it is small-scale trials in the scientific research stage or large-scale procurement in industrial production, it can accurately match demand, effectively avoid the risk of raw material supply shortages, and ensure that customer production progress is not affected. 3. Professional technical team, full process technical supportThe core technology team is composed of several senior engineers who are deeply involved in the field of peptide synthesis materials, familiar with the synthesis processes and technical difficulties of various peptide active pharmaceutical ingredients. We can provide customers with full process technical services, including recommending suitable resin models based on their peptide chain structure, providing suggestions for optimizing synthesis processes, answering technical questions during use, assisting in solving various problems that arise during resin application, and helping customers improve synthesis efficiency and reduce production costs. 4. Improve service system and enhance cooperation experienceEstablish an efficient pre-sales, in sales, and after-sales service system: provide pre-sales product selection consultation and sample trial services; Real time tracking of order production progress and logistics information during sales, providing various customized transportation methods such as room temperature and refrigeration, covering major regions across the country and the world, ensuring product safety and fast delivery; Regularly follow up with customers on their usage and respond promptly to their various needs and feedback. Support flexible payment methods and order cycles, and open a green service channel for urgent orders to maximize customer timeliness needs.
Leading Supplier of Inclisiran (CAS: 1639324-58-5) Intermediates Empowers Cardiovascular Drug Development
With continuous technological advancements in cardiovascular disease treatment, Inclisiran (CAS: 1639324-58-5) has emerged as a landmark small interfering RNA (siRNA) lipid-lowering agent. Its long-acting and precise therapeutic profile drives escalating market demand globally. To support pharmaceutical companies and research institutions in accelerating Inclisiran’s research, development, and manufacturing, we leverage a mature R&D and production platform coupled with stringent quality control standards. We now offer a comprehensive range of high-purity, stable intermediates along the entire synthetic pathway of Inclisiran, providing critical raw material support for your projects. API KSM CAS No  Inclisiran 2'-OMe N-Bz Adenosine Amidite 110782-31-5 2'-OMe N-iBu Guanosine Amidite 150780-67-9 2'-OMe N-Ac Cytidine Amidite 199593-09-4 2'-OMe Uridine Amidite 110764-79-9 2'-Fluoro N-Bz Adenosine Amidite 136834-22-5 2'-Fluoro N-iBu Guanosine Amidite 144089-97-4 2'-Fluoro N-Ac Cytidine Amidite  159414-99-0 2'-Fluoro Uridine Amidite 146954-75-8 deoxy Thymidine Amidite 98796-51-1 Core Product Portfolio Covering Key Steps in Inclisiran Synthesis Drawing on years of specialization in nucleic acid drug intermediates, our product lineup is finely tuned to meet the specific synthetic requirements of Inclisiran. The supplied intermediates cover every crucial segment and modified monomer involved in its complete synthetic process, including but not limited to: - Modified Nucleoside Intermediates: These cover a variety of ribonucleoside and deoxyribonucleoside derivatives modified at different positions, serving as the essential foundational raw materials for constructing Inclisiran’s oligonucleotide chains. - Linkers and Activation Intermediates: Special intermediates designed for efficient and specific nucleotide chain elongation and end modification, ensuring highly selective coupling reactions. - Protective Group Reagents and Derivatives: A comprehensive collection of high-performance protecting groups and modified products to precisely control protection and deprotection steps during synthesis, crucial for maintaining the integrity of functional groups in complex oligonucleotides. - Customized Intermediates: Tailored synthesis services are available to accommodate client-specific synthetic routes and structural requirements, addressing unique raw material challenges in specialized process steps. Each intermediate is optimized according to the distinctive features of Inclisiran’s synthetic procedures to guarantee optimal compatibility with subsequent reactions, thereby enhancing overall yield and product purity. By integrating advanced chemistry expertise with rigorous quality management, we are committed to delivering reliable, high-quality intermediates that accelerate the global development and manufacture of this pivotal siRNA therapeutic. Our solutions aim to empower your Inclisiran projects, ensuring seamless scale-up and robust production in this rapidly evolving field of cardiovascular treatment.

2025

12/11